In the most recent in a series of efforts intended to push it further into molecular diagnostics, Invitrogen said this week that it would collaborate with German firm Signalomics to develop nanocrystal reagents for tumor identification.

The company also said it "welcomes" existing and impending competition from small, private shops because they will eventually become "collaboration" opportunities for Invitrogen.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.